CAUWENBERGH GEERT (President & CEO) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/3/2018ACC: 0001209191-18-045456
DirectorOfficer· President & CEO
Since Aug 2018
+42K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
42K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21K
Price / share
—
Trade value
—
% of position
147.3%
8/1/2018
14.26K→35.26K
Total
Net shares
+21K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/1/2018 | A · Award | +21K | — | — | 147.3% | 14.26K | 35.26K |
| Total | +21K | $0.00 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common stock
21K shares
Shares
+21K
Strike price
1.79
Held after
21K
Exercisable
—
8/1/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common stock21K shares | 8/1/2018 | A · Award | +21K | 1.79 | — | 21K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned450.00
Total
450.00 indirect450.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 450.00 | Indirect |
| Total | 450.00 | 450.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported